Nephros, Inc. (NEPH) Financials

NEPH Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 15.8 million 3.8 million
March 31, 2026 13.8 million 3.1 million
Dec. 31, 2025 13.6 million 3.4 million
Sept. 30, 2025 13.2 million 3.2 million

NEPH Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 681000 61000
March 31, 2026 -1.7 million 60000
Dec. 31, 2025 230000 79000
Sept. 30, 2025 99000 70000

NEPH Net Income

No data available :(

NEPH Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 4.7 million - 458000
March 31, 2026 4.0 million 566000 968000
Dec. 31, 2025 5.4 million - 672000
Sept. 30, 2025 5.2 million - 1.2 million

NEPH Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 11.1 million
March 31, 2026 11.0 million
Dec. 31, 2025 11.0 million
Sept. 30, 2025 11.0 million

NEPH Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 366000 2.4 million -
March 31, 2026 - 346000 2.5 million -
Dec. 31, 2025 - 395000 2.3 million -
Sept. 30, 2025 - 338000 2.2 million -

NEPH Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 6.0 million 2.0 million
March 31, 2026 5.2 million 2.2 million
Dec. 31, 2025 4.7 million 2.1 million
Sept. 30, 2025 4.8 million 1.8 million

NEPH Revenue by Segment
Graph available only for paid members. Upgrade to see it.

NEPH

Price: $3.68

52 week price:
2.66
6.42

Payout Ratio Range:
-2909.09%
-6.99%

Earnings Per Share: 0.16 USD

P/E Ratio: 27.38

Exchange: NCM

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

Volume: 13441

Market Capitalization: 32.8 million

Links: